Skip to content

Investor Relations / Publications / Publications Search

Publications Search

Association between triglycerides and residual cardiovascular risk in patients with type 2 diabetes mellitus and established cardiovascular disease (from the Bypass Angioplasty Revascularization Investigation 2 Diabetes [BARI 2D] trial).

Nelson AJ, Navar A, Mulder H, Wojdyla D, Philip S, Granowitz C, Peterson ED, Pagidipati NJ. Association between triglycerides and residual cardiovascular risk in patients with type 2 diabetes mellitus and established cardiovascular disease (from the Bypass Angioplasty Revascularization Investigation 2 Diabetes [BARI 2D] trial). Am J Cardiol. 2020; epub ahead of print.

Reduction of revascularization in patients with hypertriglyceridemia with icosapent ethyl: insights from REDUCE-IT REVASC.

American Society for Preventive Cardiology
Peterson BE, Bhatt DL, Steg G, et al. Reduction of revascularization in patients with hypertriglyceridemia with icosapent ethyl:  insights from REDUCE-IT REVASC. Presented at the American Society for Preventive Cardiology 2020 annual meeting (virtual).

Amarin Corporation